We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+15.68%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.01B
AUM Growth
+$1.61B
Cap. Flow
+$1.27B
Cap. Flow %
31.53%
Top 10 Hldgs %
19.18%
Holding
669
New
233
Increased
133
Reduced
99
Closed
172

Top Buys

Rank Stock Value
1
CONE
CyrusOne Inc Common Stock
CONE
+$52.3M
2
ALK icon
Alaska Air
ALK
+$45.3M
3
KRC icon
Kilroy Realty
KRC
+$44.8M
4
HR icon
Healthcare Realty
HR
+$40.3M
5
DEI icon
Douglas Emmett
DEI
+$39M

Top Sells

Rank Stock Value
1
DOC icon
Healthpeak Properties
DOC
+$28.1M
2
AIG icon
American International
AIG
+$21.4M
3
LNC icon
Lincoln National
LNC
+$19.2M
4
FDC
First Data Corporation
FDC
+$16.9M
5
CXO
CONCHO RESOURCES INC.
CXO
+$16.3M

Sector Composition

Rank Sector Weight
1 Real Estate 26.53%
2 Technology 8.27%
3 Industrials 6.62%
4 Financials 6.48%
5 Utilities 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVTR
476
DELISTED
Nuvectra Corporation Common Stock
NVTR
$220K 0.01%
20,000
-2,600
-12% -$35.1K
RCKT icon
477
Rocket Pharmaceuticals
RCKT
$343M
$219K 0.01%
12,500
-1,500
-11% -$23.7K
RGEN icon
478
Repligen
RGEN
$6.91B
$207K 0.01%
+3,500
New +$201K
MDY icon
479
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$204K 0.01%
+591
New +$199K
GNK icon
480
Genco Shipping & Trading
GNK
$1.1B
$201K 0.01%
27,000
-43,935
-62% -$359K
BKS
481
DELISTED
Barnes & Noble
BKS
$190K ﹤0.01%
+35,000
New +$213K
PGNX
482
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$186K ﹤0.01%
+40,000
New +$181K
UROV
483
DELISTED
Urovant Sciences Ltd.
UROV
$151K ﹤0.01%
15,000
– –
KPTI icon
484
Karyopharm Therapeutics
KPTI
$155M
$146K ﹤0.01%
1,667
– –
CBIO
485
Crescent Biopharma
CBIO
$546M
$125K ﹤0.01%
100
-50
-33% -$57.2K
TYME
486
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$123K ﹤0.01%
70,000
– –
FENC icon
487
Fennec Pharmaceuticals
FENC
$335M
$121K ﹤0.01%
25,000
– –
TGTX icon
488
CALL
TG Therapeutics
TGTX
$8.19B
$121K ﹤0.01%
+15,000
New +$81.1K
IMDX
489
Insight Molecular Diagnostics
IMDX
$141M
$99K ﹤0.01%
+1,250
New +$80.6K
VKTX icon
490
Viking Therapeutics
VKTX
$3.88B
$99K ﹤0.01%
10,000
-10,000
-50% -$83.7K
ALIM
491
DELISTED
Alimera Sciences
ALIM
$89K ﹤0.01%
5,600
-26
-0.5% -$396
ACH
492
Accendra Health
ACH
$254M
$82K ﹤0.01%
20,000
– –
ABEO icon
493
Abeona Therapeutics
ABEO
$355M
$74K ﹤0.01%
400
– –
NTGN
494
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$71K ﹤0.01%
+11,000
New +$57.6K
OPK icon
495
Opko Health
OPK
$1.02B
$65K ﹤0.01%
25,000
-189,600
-88% -$574K
CHRN
496
ChronoScale Holdings
CHRN
$2.69B
$50K ﹤0.01%
89
– –
VLRX
497
DELISTED
VALERITAS HOLDINGS INC
VLRX
$41K ﹤0.01%
6,250
– –
AAP icon
498
CALL
Advance Auto Parts
AAP
$3.53B
– –
-14,500
Closed -$2.28M
AAP icon
499
Advance Auto Parts
AAP
$3.53B
– –
-4,769
Closed -$751K
ABBV icon
500
CALL
AbbVie
ABBV
$465B
– –
-5,000
Closed -$461K
18 19
20
21 22

Similar funds

SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, Weiss Multi-Strategy Advisers held 669 positions worth $4.01B, up 67% from $2.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Weiss Multi-Strategy Advisers deployed $1.27B of net new capital in Q1 2019, opening 233 new positions and adding to 133 existing holdings. Its largest new stake was CyrusOne Inc Common Stock: 1,000,000 shares worth $52.4M.

By sector, the portfolio is most concentrated in Real Estate at 27% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Weingarten Realty Investors, an estimated $13.5M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2019 buy was CyrusOne Inc Common Stock: 1,000,000 shares worth $52.4M.
  • Weiss Multi-Strategy Advisers added most to Kilroy Realty in Q1 2019, an estimated $44.8M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2019 reduction was Weingarten Realty Investors, cutting an estimated $13.5M.
  • Weiss Multi-Strategy Advisers fully exited Healthpeak Properties in Q1 2019, selling an estimated $28.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 19% of its $4.01B portfolio in Q1 2019.
  • Weiss Multi-Strategy Advisers opened 233 new positions and closed 172 in Q1 2019.
  • Weiss Multi-Strategy Advisers's portfolio value rose 67% quarter-over-quarter to $4.01B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.